The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy.
about
Photoreceptor inner segment ellipsoid band integrity on spectral domain optical coherence tomographyOne-year results of reduced fluence photodynamic therapy for central serous chorioretinopathy: the outer nuclear layer thickness is associated with visual prognosis.Half-dose verteporfin combined with half-fluence photodynamic therapy for chronic central serous chorioretinopathy.Characterization of outer retinal morphology with high-speed, ultrahigh-resolution optical coherence tomography.Feasibility of a method for en face imaging of photoreceptor cell integrity.The association between percent disruption of the photoreceptor inner segment-outer segment junction and visual acuity in diabetic macular edemaAssociation between hyperacuity defects and retinal microstructure in polypoidal choroidal vasculopathyLong-term results of half-dose photodynamic therapy for chronic central serous chorioretinopathy with contrast sensitivity changes.ERK-mediated activation of Fas apoptotic inhibitory molecule 2 (Faim2) prevents apoptosis of 661W cells in a model of detachment-induced photoreceptor cell deathCadherin 5 is regulated by corticosteroids and associated with central serous chorioretinopathyRelationship between photoreceptor outer segment length and visual acuity in diabetic macular edema.The effect of Helicobacter pylori treatment on remission of idiopathic central serous chorioretinopathyCentral serous chorioretinopathy: update on pathophysiology and treatment.Factors influencing the visual acuity of chronic central serous chorioretinopathyAutophagy activation in the injured photoreceptor inhibits fas-mediated apoptosis.Fourier-domain optical coherence tomography of eyes with idiopathic epiretinal membrane: correlation between macular morphology and visual function.The association between choroidal thickness variations and response to intravitreal bevacizumab in central serous chorioretinopathy.Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials.Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial.Ultrahigh-resolution optical coherence tomography in patients with decreased visual acuity after retinal detachment repair.Ultra-high resolution optical coherence tomography assessment of photoreceptors in retinitis pigmentosa and related diseases.Spectral-domain OCT in anti-VEGF treatment of myopic choroidal neovascularization.Low-Fluence Photodynamic Therapy versus Subthreshold Micropulse Yellow Wavelength Laser in the Treatment of Chronic Central Serous Chorioretinopathy.Changes in Choroidal Structures in Eyes with Chronic Central Serous Chorioretinopathy after Half-Dose Photodynamic TherapyThe IS/OS junction layer in the natural history of type 2 idiopathic macular telangiectasiaAssociation between integrity of foveal photoreceptor layer and visual acuity in branch retinal vein occlusion.Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).Predictors of visual outcome in eyes with choroidal neovascularization secondary to age related macular degeneration treated with intravitreal bevacizumab monotherapy.Oral Mineralocorticoid-Receptor Antagonists: Real-Life Experience in Clinical Subtypes of Nonresolving Central Serous Chorioretinopathy With Chronic Epitheliopathy.Control of photoreceptor autophagy after retinal detachment: the switch from survival to death.High-Resolution Imaging of Intraretinal Structures in Active and Resolved Central Serous Chorioretinopathy.En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathyPersistent subretinal fluid after surgery for rhegmatogenous retinal detachment: hypothesis and review.Central serous chorioretinopathy: a review of epidemiology and pathophysiology.Predicting visual outcomes for macular disease using optical coherence tomography.Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review.Comparison of visual and anatomical outcomes of half-fluence and half-dose photodynamic therapy in eyes with chronic central serous chorioretinopathy.Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy.Clinical experience with eplerenone to treat chronic central serous chorioretinopathy.Inhibition of retinal detachment-induced apoptosis in photoreceptors by a small peptide inhibitor of the fas receptor
P2860
Q27021797-CDA3961C-413E-4254-9B69-B5D1F34504B0Q31112014-31F7A43B-0505-4A32-AB46-791A41405111Q33705962-A41D4A0D-D6D5-4663-88F3-09DB940D43B8Q33755559-EF9629E9-2886-4E18-B3E1-9F3A000A2F93Q33963125-D44C2FC4-750E-43B8-929E-960E25AA2781Q33976725-7F8B8A7E-06B8-4C81-9B44-730101C7A16AQ34039123-60D6E34A-9420-491F-945A-56651CA95863Q34334673-EDEF55BF-A65F-4599-9202-C74AD8F1E189Q34431463-DD809200-E7B2-4DA0-AB94-B934489DDCC1Q34434358-16318A57-5F4E-49ED-9096-1283E577E455Q34492289-9986D13E-225B-473C-8A0B-A994CAA62C74Q34493875-EB9C0230-9BCA-4341-9D74-70F3EED56B87Q34587658-4C8F7DAE-035F-4649-A0A1-A165CC66376AQ34695063-73043375-BF66-45B8-9C07-DB747321C113Q35220985-17D259AE-12AC-435B-B35E-B790FF1B00FEQ35226650-439EE472-5B43-45C9-8338-FA606DB82AF3Q35657257-3BE18665-D84E-4FAE-B8F1-B8332D3F45DEQ35682910-5966A3E1-C317-47F2-8D91-6FA9BCB9A149Q35782233-D3893842-BDFA-493A-9D1D-2A6B9D580A56Q35925336-6B6C6B1F-678C-40BA-BC28-9945FE041EA7Q35928716-56FEC317-E7DD-494B-8D49-4ABC3E1DB84AQ36093290-50B394EE-C637-48D6-A1AD-22E7AA805579Q36123646-F69D3C08-2256-42E2-BC36-C6C6D08BFB8DQ36135515-49281D45-F2DC-4E4E-8F7B-B56754446F7EQ36164500-9B331CF4-0C82-4750-AA54-CB8E9BAC786FQ36172370-ABF191CC-D8C0-443D-9E15-8C9106209CEFQ36407625-3DA17276-7D7C-43B4-9E33-487849AC67BDQ36632445-DE7C45D4-DE17-4B7F-8A57-C4FFCD1C8DD1Q36663776-B3631624-CADC-4F42-A263-9B18F474DC4AQ37561222-7B1FC04C-A913-4B84-ADE8-31EE8C5F66D6Q37579624-DBF5FDF8-F2E9-4E76-80F6-B38239D18549Q37619588-11A29561-3D37-4AF4-9B9E-28E069088E89Q37974820-578D91DD-FDBF-4F2E-AB52-7B52758D5639Q38025702-B6307983-FBB1-4EFC-9634-82136888D5F3Q38130239-A3107A4F-8637-4439-96D0-F54FF50BB8A4Q38160720-509DB392-23B8-4A49-8028-B3ABBA7AEA7EQ38330486-2C94366A-6C35-4AE7-B59D-7D1243F20215Q38701151-26BF8347-F643-4A72-A955-CC47E9839A0EQ38825598-A2A82A04-962B-4D27-A640-240CD53F1209Q40503135-0E34A178-CE82-4727-8D04-AD661D3584DC
P2860
The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The foveal photoreceptor layer ...... tral serous chorioretinopathy.
@ast
The foveal photoreceptor layer ...... tral serous chorioretinopathy.
@en
type
label
The foveal photoreceptor layer ...... tral serous chorioretinopathy.
@ast
The foveal photoreceptor layer ...... tral serous chorioretinopathy.
@en
prefLabel
The foveal photoreceptor layer ...... tral serous chorioretinopathy.
@ast
The foveal photoreceptor layer ...... tral serous chorioretinopathy.
@en
P2093
P1476
The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy
@en
P2093
Ali' Abdollahi
Felice Cardillo Piccolino
Giambattista Ravera
Luca Ventre
Marilisa Manea
Roberta Rigault de la Longrais
P356
10.1016/J.AJO.2004.08.037
P407
P577
2005-01-01T00:00:00Z